Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Multiple Myeloma 2Recurrence 1Peripheral Nervous System Diseases 1Neoplasms, Plasma Cell 1

Interventions

Dexamethasone 3Bortezomib 3Acupuncture Therapy 3Tablets 1Lenalidomide 1Glutamine 1G(M1) Ganglioside 1Fenofibrate 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peripheral Nervous System Diseases × Glutamine × Plasma cell × Clear all
NCT01783522 2019-10-22

Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

Case Comprehensive Cancer Center

Phase 2 Terminated
9 enrolled 10 charts
Plasma cell

Multiple Myeloma, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡